Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
UK |
|
UGI Corp
NYSE:UGI
|
US |
|
Brixmor Property Group Inc
NYSE:BRX
|
US |
|
Nomad Foods Ltd
NYSE:NOMD
|
UK |
|
F
|
First Community Corp (South Carolina)
NASDAQ:FCCO
|
US |
|
Fairfax Financial Holdings Ltd
TSX:FFH
|
CA |
|
Afya Ltd
NASDAQ:AFYA
|
BR |
|
Elecnor SA
MAD:ENO
|
ES |
|
Armstrong World Industries Inc
NYSE:AWI
|
US |
|
DLF Ltd
NSE:DLF
|
IN |
|
M
|
Magis SpA
MIL:MGS
|
IT |
|
I
|
Ishii Iron Works Co Ltd
TSE:6362
|
JP |
|
Imricor Medical Systems Inc
ASX:IMR
|
US |
|
Citigroup Inc
NYSE:C
|
US |
Bankruptcy Probability
Centessa Pharmaceuticals PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Centessa Pharmaceuticals PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
6.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
381.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Centessa Pharmaceuticals PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Centessa Pharmaceuticals PLC has total debt of 110.1m USD. This includes both short-term (0 USD) and long-term (110.1m USD) debt.
You can find a full breakdown on its Balance Sheet.
